Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2000
03/08/2000CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them
03/07/2000US6034298 The vaccine is administered through the consumption of the edible plant as food, preferably in the form of a fruit or vegetable juice which can be taken orally.
03/07/2000US6034275 Tertiary amines
03/07/2000US6034223 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
03/07/2000US6034134 1-Amino-alkylcyclohexane NMDA receptor antagonists
03/07/2000US6034129 Ionic polymers as anti-infective agents
03/07/2000US6034086 Viricides; aids therapy
03/07/2000US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/07/2000US6034076 Antibiotics; bactericides
03/07/2000US6034070 Veterinary medicine
03/07/2000US6033886 Recombinant infectious non-segmented negative strand RNA virus
03/07/2000US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033844 Porcine reproduction respiratory syndrome diagnostic
03/07/2000US6033672 Method of stimulating an immune response to caprine arthritis-encephalitis virus (CAEV) in humans through the administration of CAEV immunogens
03/07/2000US6033670 Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus
03/07/2000US6033668 Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
03/07/2000US6033662 Oxygen activatable formulations for disinfection or sterilization
03/07/2000CA2007935C Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
03/07/2000CA2001168C Substituted 2-aminothiazoles
03/02/2000WO2000011207A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS
03/02/2000WO2000011187A1 Molecular sequence of swine retrovirus and methods of use
03/02/2000WO2000011183A2 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011036A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120
03/02/2000WO2000011023A2 Ring modified cyclic peptide analogs
03/02/2000WO2000011015A1 Secreted proteins and polynucleotides encoding them
03/02/2000WO2000010999A2 New compounds
03/02/2000WO2000010991A1 Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs
03/02/2000WO2000010968A2 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000WO2000010967A1 Novel aryl sulphonamides and analogues
03/02/2000WO2000010611A2 Drug targeting
03/02/2000WO2000010600A2 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents
03/02/2000WO2000010599A2 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
03/02/2000WO2000010591A1 Peptides for inhibition of herpes simplex virus entry
03/02/2000WO2000010582A2 Probiotic, lactic acid-producing bacteria and uses thereof
03/02/2000WO2000010573A1 Compounds, compositions and methods for treating or preventing viral infections and associated diseases
03/02/2000WO2000010569A1 Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both
03/02/2000WO2000010566A1 Novel isoxazolinone antibacterial agents
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO2000010562A1 Physically stable and x-ray amorphous form of hydrochloride ranitidine having an increased anti-ulcer activity and method for producing the same
03/02/2000WO2000010549A1 Regulation of substrate activity
03/02/2000WO2000010532A1 Dinitroaniline liposomal formulations and processes for their preparation
03/02/2000WO2000010385A1 Method of enhancing catheter patency using a citrate salt catheter lock solution
03/02/2000WO1999065513A3 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
03/02/2000WO1999065511A3 Composition and method for treatment of pseudomonas infection
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/02/2000WO1999063093A3 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
03/02/2000WO1999061620A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
03/02/2000WO1999061614A3 Human socs proteins
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999057271A3 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
03/02/2000WO1999055377A9 Polyol-ifn-beta conjugates
03/02/2000WO1999052547A9 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
03/02/2000WO1999035912A8 Tuberculocidal disinfectant
03/02/2000WO1999024578A3 Neisserial antigens
03/02/2000DE19839096A1 A cytokine-inducible gene and related protein useful for modulation of interferon gamma
03/02/2000DE19838462A1 Aseptic herbal liquid useful as drink or tincture for poultices
03/02/2000DE19827457C1 Strukturprotein von AAV, seine Herstellung und Verwendung AAV structural protein, its preparation and use
03/02/2000CA2342162A1 Drug targeting
03/02/2000CA2341970A1 Compounds, compositions and methods for treating or preventing viral infections and associated diseases
03/02/2000CA2341742A1 Activation and protection of t-cells (cd4+ and cd8+) using an h2 receptor agonist and other t-cell activating agents
03/02/2000CA2341637A1 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000CA2341540A1 Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs
03/02/2000CA2341370A1 Novel substituted triazole compounds
03/02/2000CA2341309A1 Use of mcrp for delivery of materials into cells
03/02/2000CA2341271A1 Novel isoxazolinone antibacterial agents
03/02/2000CA2341028A1 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000CA2340928A1 Novel arylsulphonamides and analogues
03/02/2000CA2340787A1 An anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
03/02/2000CA2340692A1 Immunogenic .beta.-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
03/02/2000CA2340676A1 Ring modified cyclic peptide analogs
03/02/2000CA2340616A1 Secreted proteins and polynucleotides encoding them
03/02/2000CA2340457A1 14400 receptor, a g-protein coupled receptor
03/02/2000CA2340277A1 Human rna-associated proteins
03/02/2000CA2339537A1 Regulation of substrate activity
03/02/2000CA2339372A1 New compounds
03/02/2000CA2306747A1 Dinitroaniline liposomal formulations and processes for their preparation
03/01/2000EP0982405A2 Recombinant alphavirus vectors
03/01/2000EP0982403A1 Swine vesicular disease virus and mutant strains and preparation process and use thereof
03/01/2000EP0982037A1 Preventives and/or remedies for sepsis
03/01/2000EP0981646A1 Enzymatic dna molecules
03/01/2000EP0981625A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
03/01/2000EP0981544A2 Anti-bacterial methods and materials
03/01/2000EP0981532A1 Acyclovir diester derivatives
03/01/2000EP0981527A1 Salt of naphthyridine carboxylic acid derivative
03/01/2000EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors
03/01/2000EP0981372A2 Compositions of antichlamydial agents for the diagnosis and management of infection caused by chlamydia
03/01/2000EP0981361A1 Method of treating sepsis
03/01/2000EP0981336A2 Use of peroxygen compounds in the control of hairy wart disease
03/01/2000EP0981335A1 An enteric coated oral dosage form comprising sodium amoxycillin
03/01/2000EP0804230B1 Vaccine against mycobacterial infections
03/01/2000EP0702564B1 Novel attenuated pseudomonas aeruginosa strains
03/01/2000EP0641341B1 METHOD FOR PREPARING BENZO [b]NAPHTHYRIDINES
03/01/2000CN1246151A Mutants of streptococcal toxin A and methods of use
03/01/2000CN1246126A Antimicrobially active polypeptides
03/01/2000CN1246123A Novel erythromycin derivatives, method of preparation and application as medicines
03/01/2000CN1246120A Imidazopyridazines compound
1 ... 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 ... 1798